NephTech is a medical technology company dedicated to provide patients and dialysis centres an evidence-based approach to vascular access surveillance and management. Vascular access is end stage renal disease (commonly known as kidney failure) patient’s lifeline, as it allows removal of body waste through hemodialysis, and without which patients do not survive beyond several days. 

Among other innovations, the company is developing an economically feasible and revolutionary vascular access surveillance technology for dialysis centres to leapfrog quality of care and reduce cost inefficiencies through early prediction of vascular complications.  

This, NephTech strongly believes, will address a vital unmet need to reduce the heavy financial expenditures in the hemodialysis space.